KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Cancer / 2002 / Cilt: 32 - Sayı: 2

The evaluation of p53 and Ki-67 expressions in invasive micropapillary carcinoma of the breast and its relation with other prognostic parameters: Thirty two cases

Banu LEBE
Tülay CANDA
Burçin TUNA
Özgül SAĞOL
Erdener ÖZER
Sayfa
48–56
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

There was no significant difference between the cases of pure invasive micropapillary carcinoma and the cases of partial invasive micropapillary carcinoma for tumor size, Iymph node metastasis, ER and PR status and c-erbB-2 expressions (p>0.05).

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:This study aimed assess the expression of p53 and Ki-67 antigen and to evaluate its relation with the other prognostic parameters in pure and partial type of invasive micropapillary carcinoma of the breast in thirty two cases.
📊
Temel Bulgular & Veri:Immunohistochemical staining was performed for p53 and Ki-67 antibodies.
💡
Sonuç & Katkı:There was no significant difference between the cases of pure invasive micropapillary carcinoma and the cases of partial invasive micropapillary carcinoma for tumor size, Iymph node metastasis, ER and PR status and c-erbB-2 expressions (p>0.05).
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Ki-67 antijeni · Meme neoplazmları · Karsinom

Abstract

This study aimed assess the expression of p53 and Ki-67 antigen and to evaluate its relation with the other prognostic parameters in pure and partial type of invasive micropapillary carcinoma of the breast in thirty two cases. Immunohistochemical staining was performed for p53 and Ki-67 antibodies. Statistical analysis was performed for comparing the expression of p53 and proliferative activity index with tumor size, Iymph node metastasis, estrogen and progesterone receptor status and c-erbB-2 expression in pure and partial invasive micropapillary carcinoma. In our series, there was no correlation of Ki-67 and expressions between tumor size, Iymph node metastasis, estrogen receptor (ER) status, progesteron receptor (PR) status, and c-erbB-2 expressions (p>0.05). There was no significant difference between the cases of pure invasive micropapillary carcinoma and the cases of partial invasive micropapillary carcinoma for tumor size, Iymph node metastasis, ER and PR status and c-erbB-2 expressions (p>0.05).

🔖

Bu Makaleye Atıf Yap

LEBE, B., CANDA, T., TUNA, B., SAĞOL, Ö., ÖZER, E. (2002). The evaluation of p53 and Ki-67 expressions in invasive micropapillary carcinoma of the breast and its relation with other prognostic parameters: Thirty two cases. Turkish Journal of Cancer, Cilt: 32 - Sayı: 2, 48–56. https://ajindex.com/articles/368366

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Paterakos M, Watkin WG, Edgerton SM, et al. Invasive micropapillary carcinoma of the breast: A prognostic study. Hum Pathol 1999;30:1459-63
  2. Lee AH, Telfer TP, Millis RR. Metastatic breast carcinoma with appearance resembling micropapillary ductal carcinoma in situ. J Clin Pathol 1995;48:380-2
  3. Luna-More S, Gonzales B, Acedo C, et al. Invasive micropapillary carcinoma of the breast. A new special type of invasive mammary carcinoma. Pathol Res Pract 1994;190:668-74
  4. Luna-More S, de los Santos F, Breton JJ, et al. Estrogen and progesterone receptors, c-erbB-2, p53, and Bcl-2 in thirty-three invasive micropapillary breast carcinomas. Pathol Res Pract 1996;192:27-32
  5. Tresserra F, Grases PJ, Fabregas R, et al. Invasive micropapillary carcinoma. Distinct features of a poorly recognized variant of breast carcinoma. Eur J Gynaecol Oncol 1999;20:205-8
  6. Canda T, Sağol Ö, Özer E, et al. Memenin invaziv mikropapiller karsinomu (7 olgu). Türkiye Ekopatoloji Dergisi 1996;2:92-5
  7. Luna-More S, Casquero S, Perez-Mellado A, et al. Importance of estrogen receptors for the behavior of invasive micropapillary carcinoma of the breast. Review of 68 cases with follow-up of 54. Pathol Res Pract 2000;196:35-9
  8. Walsh MM, Bleiweiss IJ. Invasive micropapillary carcinoma of the breast: Eighty cases of an underrecognized entity. Hum Pathol 2001;32:583-9
  9. Nassar H, Wallis T, Andea A, et al. Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. Mod Pathol 2001;14:836- 41
  10. Friedrich MG, Riethdorf S, Erbersdobler A, et al. Relevance of p53 gene alterations for tumor recurrence in patients with superficial transitional cell carcinoma of the bladder. Eur Urol 2001;39:159-66
  11. De Manzoni G, Verlato G, Tomezzoli A. Study on Ki-67 immunoreactivity as a prognostic indicator in patients with advanced gastric cancer. Jpn J Clin Oncol 1998;28:534-7
  12. Fisher ER, Costantino J, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4): Discriminants for 15- year survival. National Surgical Adjuvant Breast and Bowel Project Investigators. Cancer 1993;71:2141-50
  13. Siriaunkgul S, Tavassoli FA. Invasive micropapillary carcinoma of the breast. Mod Pathol 1993;6:660-2
  14. Middleton LP, Tressera F, Sobel ME, et al. Infiltrating micropapillary carcinoma of the breast. Mod Pathol 1999;12:499-504.